What’s in a name: Agencies struggle to keep up with expanding drug space
With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.
NICE recommends use of Wolman disease therapy in babies
Everest Medicines gains NMPA approval in China for IgAN therapy
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
FDA grants orphan drug status for Arcturus’ cystic fibrosis therapy
Signal: British biopharma applies for BLA for T-cell cancer therapy
Analysis
View More
Themes
View MoreIGC Pharma signs agreement to adopt AI solutions into drug discovery
The company plans to use AI algorithms in trials to boost efficiency in study progression, cost-cutting and data evaluations.
More themes
Premium Insights
View MoreLeading innovators in nucleotide analogues for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Genentech and NVIDIA enter generative AI-powered drug discovery deal
Daiichi Sankyo signs agreement with Japan to supply Covid-19 vaccine
COP27: Have we committed to our goals?
Almirall and Absci partner on AI-driven dermatological drug development